Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

26

Revenue 2017

Victoza

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Victoza was produced by Novo Nordisk.

Givlaari, Rybelsus lead crowded CHMP recommendations

Givlaari, Rybelsus lead crowded CHMP recommendations

Lilly’s SGLT2 inibitor Jardiance (empagliflozin) and Victoza, as well as placebo.

Novo bolstered by new diabetes, obesity products

Novo bolstered by new diabetes, obesity products The once-weekly injectable GLP-1 agonist has continued to offset declines of Novo’s older drugs, including the one-daily shot Victoza (liraglutide).

Novo Nordisk gets FDA okay for new diabetes hope

Novo Nordisk gets FDA okay for new diabetes hope Sales of Victoza fell 5% in the first half of the year to around $1.6bn, and while the decline was more than offset by growth by Ozempic’s $550m contribution ... to Reuters, and that would make it a larger product than Victoza at its peak.

Novo Nordisk shareholder revolt reaches Europe

Novo Nordisk shareholder revolt reaches Europe Novo Nordisk has latterly become less reliant on sales of its insulin products as newer products, particularly GLP-1 agonists Victoza (liraglutide) and Ozempic (semaglutide), have increased their share of revenues.

Lilly’s Trulicity cuts heart and kidney risks in diabetes by 12%

Lilly’s Trulicity cuts heart and kidney risks in diabetes by 12% Trulicity's growth to date has stemmed largely from its once-weekly dosing, which proved a popular alternative to daily GLP-1 agonists such as Novo Nordisk's older drug Victoza ... empagliflozin) equivalent to once-daily injectable Victoza at both six-

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Havas Lynx Group

We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...

Latest intelligence

Could formulary intelligence be your brand differentiator?
Proprietary research, and the COVID-19 experience, shows how formulary intelligence can drive competitive advantage at launch...
Lara Meyer
How COVID-19 is accelerating the threat of antimicrobial resistance
Why antimicrobial resistance needs to be addressed with the same urgency as COVID-19...
Improve clinical trials through patient journey mapping
Could patient journey mapping be your solution to improving clinical study recruitment and retention? While awareness of clinical studies is low across the population, it’s not the only issue. It’s...

Infographics